PGM1CDG

PGM1CDG refers to Phosphoglucomutase 1 Congenital Disorder of Glycosylation. This is a rare genetic disorder that affects the production of essential sugar molecules called N-glycans. These N-glycans are crucial for the proper folding, stability, and function of many proteins within the body. The disorder is caused by mutations in the PGM1 gene, which provides instructions for making an enzyme important in glucose metabolism. This enzyme plays a role in the pathway that generates the building blocks for N-glycans.

The symptoms of PGM1CDG can vary widely among affected individuals, even within the same family. Common manifestations include developmental delays, intellectual disability, and muscle weakness. Other potential issues can involve the liver, heart, and eyes. The severity and specific combination of symptoms depend on the exact nature of the mutation and how it impacts the enzyme's function. Diagnosis typically involves biochemical testing to detect characteristic patterns of abnormal glycosylation and genetic testing to confirm mutations in the PGM1 gene. There is no cure for PGM1CDG, but management focuses on addressing specific symptoms and providing supportive care. Treatments may involve dietary interventions, such as the use of mannose, to help bypass the metabolic defect and improve N-glycan production. Ongoing research aims to better understand the disease mechanisms and develop more targeted therapies.